ATLANTA – The Eclipsys Corporation has added some strength to the ‘Outcomes’ portion of its ‘The Outcomes Company’ moniker with the purchase of Enterprise Performance Systems, Inc., a St. Louis-based provider of financial solutions.
Eclipsys acquired all of EPSi’s issued and outstanding capital stock for approximately $53 million in cash. The company then raised its projected revenues for 2008 by $10 million, from a range of $506 million to $518 million to $516 million-$528 million.
“The acquistion of EPSi reinforces our commitment to the financial decision support space,” said R. Andrew Eckert, Eclipsys’ president and CEO. “ We look forward to building on our company’s leadership position in this market.”
Based in Atlanta, Eclipsys provides clinical, revenue cycle, access management and business performance software and service to healthcare providers, based primarily around the Sunrise suite of products. Two of its clients, the University Health System of San Antonio, Texas and St. Clair Hospital in Pittsburgh, recently received Stage 6 ranking from the Healthcare Information and Management Systems Society (HIMSS) Analytics EMR Adoption Model, the highest milestone currently conferred by HIMSS Analytics for EMR adoption.
Like Eclipsys’ solutions, EPSi’s solutions are based on the Microsoft SQL platform, making them Web-based, scalable, flexible and easy to implement. The addition of the EPSi product suite is designed to accelerate Eclypsis’ timeline for delivering an SQL-based business decision support solution.
“Eclipsys and EPSi are a winning combination for our clients and the market, as both companies are committed to delivering clients real value and real results,” said Tim Rutledge, EPSi’s president. Eckert said Rutledge and his employees are expected to continue their employment.
EPSi’s more recent clients include Health First and the St. Joseph Health System. Last September, EPSi and San Francisco-based Quantros announced a partnership to integrate that firm’s quality, compliance and risk management solutions and analytic support tools to EPSi’s product line.